EUVIMEDEUVIMED entdecken
Crossref

Peptide/Doxorubicin Co-Assembled Hydrogel for Hemostatic Control and Sustained Local Chemotherapy after Tumor Surgery

Chongbin Bai, Zhanpeng Miao, Mengting Yuan, Xin Chen, Yiyi He, Heng Zhao, Zheyi Liu, Zhihai Li iD, Siqi Guo, Fangjun Wang iD, Lei Wang, Jia Jin iD und 2 weitere

Molecular Pharmaceutics · 02.02.2026 · 23 (2) · 916-931

DOI: 10.1021/acs.molpharmaceut.5c01326 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 19.01.2026. Verfasst von Chongbin Bai und 13 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China. Hauptthemen laut MEDLINE: Doxorubicin, Peptides, Hydrogels, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinPeptidesHydrogelsNeoplasmsHemostaticsAnimalsHumansMiceDrug Delivery SystemsCell Line, TumorHemostasisDrug LiberationFemaleAntibiotics, Antineoplastic

Stichwörter der Autor:innen

antitumorco-assemblyhemostasislocalized drug deliverypeptide hydrogel

Substanzen

DoxorubicinPeptidesHydrogelsHemostaticsAntibiotics, Antineoplastic

Autor:innen und Institutionen

  • College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China.
  • State Key Laboratory of Molecular Reaction Dynamics, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China.
  • University of Chinese Academy of Sciences, Beijing 100049, China.
  • School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.
  • Department of Hand Surgery, Huashan Hospital, Fudan University, Shanghai 200040, China.

ORCID-Profile: Zhihai Li, Fangjun Wang, Jia Jin, Fei Ye

Förderung

  • National Key Research and Development Program of China
  • Dalian Institute of Chemical Physics, Chinese Academy of Sciences
  • National Natural Science Foundation of China
  • Chinese Academy of Sciences
  • Natural Science Foundation of Zhejiang Province
  • Science Foundation of Zhejiang Sci-Tech University

Zitieren

APA

Bai, C., Miao, Z., Yuan, M., Chen, X., He, Y., Zhao, H., Liu, Z., Li, Z., Guo, S., Wang, F., Wang, L., Jin, J., Liu, Y., & Ye, F. (2026). Peptide/Doxorubicin Co-Assembled Hydrogel for Hemostatic Control and Sustained Local Chemotherapy after Tumor Surgery. Molecular Pharmaceutics, 23(2), 916-931. https://doi.org/10.1021/acs.molpharmaceut.5c01326

Vancouver

Bai C, Miao Z, Yuan M, Chen X, He Y, Zhao H, et al. Peptide/Doxorubicin Co-Assembled Hydrogel for Hemostatic Control and Sustained Local Chemotherapy after Tumor Surgery. Molecular Pharmaceutics. 2026;23(2):916-931. doi:10.1021/acs.molpharmaceut.5c01326

BibTeX
@article{Bai2026,
  author = {Bai, Chongbin and Miao, Zhanpeng and Yuan, Mengting and Chen, Xin and He, Yiyi and Zhao, Heng and Liu, Zheyi and Li, Zhihai and Guo, Siqi and Wang, Fangjun and Wang, Lei and Jin, Jia and Liu, Yuzhou and Ye, Fei},
  title = {Peptide/Doxorubicin Co-Assembled Hydrogel for Hemostatic Control and Sustained Local Chemotherapy after Tumor Surgery},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  volume = {23},
  number = {2},
  pages = {916--931},
  doi = {10.1021/acs.molpharmaceut.5c01326}
}
Kostenlos starten →